Literature DB >> 28560950

MALAT1 Promotes the Proliferation and Metastasis of Osteosarcoma Cells By Activating the Rac1/JNK Pathway Via Targeting MiR-509.

Yong Zhang1, Qingfeng Dai2, Fanying Zeng2, Haichun Liu3.   

Abstract

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long noncoding RNA (lncRNA) that contributes to the initiation and development of many solid tumors, including osteosarcoma (OS). In this study, we showed that MALAT1 was increased in human OS tissues and cell lines. MALAT1 knockdown suppressed OS cell growth and metastasis, induced OS cell apoptosis and delayed tumor growth in an OS xenograft model. We also detected downregulation of microRNA-509 (miR-509), a suppressor of OS growth, in OS tissues and cell lines. Then, we identified that miR-509 is a direct target of MALAT1 and Ras-related C3 botulinum toxin substrate 1 (Rac1) is a direct target of miR-509. MALAT1 may promote OS cell growth through inhibition of miR-509, leading to the activation of Rac1/JNK pathway. Our results suggest a MALAT1/miR-509/Rac1 axis that mediates OS cell proliferation and tumor progression.

Entities:  

Year:  2018        PMID: 28560950     DOI: 10.3727/096504017X14957939026111

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  16 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

Review 3.  Fixing the GAP: The role of RhoGAPs in cancer.

Authors:  Gabriel Kreider-Letterman; Nicole M Carr; Rafael Garcia-Mata
Journal:  Eur J Cell Biol       Date:  2022-02-10       Impact factor: 6.020

4.  Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.

Authors:  Zhi-Chang Zhang; Chun Tang; Yang Dong; Jing Zhang; Ting Yuan; Xiao-Lin Li
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

5.  miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.

Authors:  Rong-Jun Cui; Jia-Lin Fan; Yu-Cui Lin; Yu-Jia Pan; Chi Liu; Jia-Hui Wan; Wei Wang; Zheng-Yuan Jiang; Xiu-Lan Zheng; Jie-Bing Tang; Xiao-Guang Yu
Journal:  Cancer Med       Date:  2019-08-29       Impact factor: 4.452

6.  lncRNA/circRNA‑miRNA‑mRNA ceRNA network in lumbar intervertebral disc degeneration.

Authors:  Jinwen Zhu; Xinliang Zhang; Wenjie Gao; Huimin Hu; Xiaodong Wang; Dingjun Hao
Journal:  Mol Med Rep       Date:  2019-08-07       Impact factor: 2.952

7.  Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression.

Authors:  Nana Ma; Shaoru Li; Quanhua Zhang; Hongmei Wang; Haixia Qin; Shijin Wang
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

Review 8.  Long noncoding RNAs in osteosarcoma via various signaling pathways.

Authors:  Jinming Han; Xiaohan Shen
Journal:  J Clin Lab Anal       Date:  2020-04-06       Impact factor: 2.352

9.  Long non-coding RNA NEAT1 promotes migration and invasion of oral squamous cell carcinoma cells by sponging microRNA-365.

Authors:  Xiaohua Liu; Wenzhi Shang; Fuju Zheng
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

10.  miR-224-5p protects dental pulp stem cells from apoptosis by targeting Rac1.

Authors:  Wenlan Qiao; Dong Li; Qing Shi; Huanhuan Wang; Hao Wang; Jing Guo
Journal:  Exp Ther Med       Date:  2019-11-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.